-
People and CultureNovartis partners with Special Olympics World Winter Games Switzerland 2029
Novartis partners with the Special Olympics to support neuro‑inclusion and build environments where everyone belongs.
People and Culture -
People and CultureFull Circle: A Story of Growth, Purpose and Coming Home to Novartis
Polly Cooper, Clinical Development Function Head, UK
People and Culture -
New long term social impact and sustainability targets
Novartis has announced new long-term Social Impact & Sustainability (SI&S) targets and goals, reinforcing our commitment to go beyond breakthroughs to maximize the impact of our medicines to support inclusive, resilient healthcare systems worldwide.
-
Access to HealthcareWorking with communities to close gaps in heart disease and cancer care
Our innovations matter only when they reach the people who need them. Yet millions live with heart disease or cancer without knowing it or have limited access to care – especially those in low-income, rural or other hard-to-reach communities.
Access to Healthcare -
Patient PerspectivesManaging Quality of Life with CML
How shared decision-making can support living well from the start with chronic myeloid leukemia
Patient Perspectives -
People and CultureBuilding the Future: Novartis Innovation Lab - AI, Game Studio, XR & Emerging Tech
The leaders behind the Novartis Innovation Lab share how they are leveraging emerging technologies to win for patients.
People and Culture -
From Our LabsBringing proteins together to take cancer apart
A Q&A with Jake Haling, Head of Oncology Drug Discovery in San Diego, on induced proximity and how it could open new paths to treat cancer.
From Our Labs -
People and CultureTurning personal experience into purpose-driven careers
What drives someone to dedicate their career to reimagining medicine? Three women at Novartis share their deeply personal and unique stories.
People and Culture -
People and CultureSupercharging R&D: How AI helps us to bring medicines to patients faster
Max leads AI innovation in pharmaceutical development at Novartis. His story reflects how cutting-edge technology is combined with human expertise for meaningful impact.
People and Culture -
DiscoveryBreaking ground in Global Health
Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery
Discovery -
Victor Bulto and Thierry Diagana named to 2026 TIME100 Health List
Novartis is proud to share that TIME has recognized Victor Bultó and Thierry Diagana among the most influential people shaping the future of health. Learn more about what drives our honorees.
-
DiscoveryWhat's next in Neuroscience drug discovery
A Q&A with Bryan Laffitte, who leads a Novartis team that’s using the tools of genetic medicine to innovate new therapies for neuromuscular and neurodegenerative conditions.
Discovery